Biotest AG
XBER:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
XBER:BIO
|
DE |
|
I
|
IHI Corp
SWB:IWJ
|
JP |
|
K
|
Kajima Corp
XBER:KAJ
|
JP |
|
D
|
D'Ieteren Group NV
SWB:DJDA
|
BE |
|
C
|
CF Industries Holdings Inc
XBER:C4F
|
US |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
|
C
|
CP All PCL
SET:CPALL
|
TH |
|
S
|
SISB PCL
SET:SISB
|
TH |
|
CubeSmart
NYSE:CUBE
|
US |
|
Spire Global Inc
NYSE:SPIR
|
US |
|
T
|
Teradyne Inc
F:TEY
|
US |
|
Wacker Neuson SE
F:WAC
|
DE |
|
Grifols SA
MAD:GRF
|
ES |
|
W
|
WEX Inc
F:WL9
|
US |
|
Obsidian Energy Ltd
TSX:OBE
|
CA |
|
Valeo SE
PAR:FR
|
FR |
|
KHD Humboldt Wedag Vermoegensverwaltungs-AG
F:HETA
|
DE |
|
CP Axtra PCL
SET:CPAXT
|
TH |
|
Royal Bank of Canada
TSX:RY
|
CA |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
R
|
Ramkhamhaeng Hospital PCL
SET:RAM
|
TH |
|
Compagnie de Saint Gobain SA
OTC:CODGF
|
FR |
Bankruptcy Probability
Biotest AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biotest AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Biotest AG
XETRA:BIO
|
1.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biotest AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biotest AG has total debt of 639.8m EUR. This includes both short-term (0 EUR) and long-term (639.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
